nach oben

Diabetologia

Erschienen in:

01.10.2006 | Article

The impact of the mTOR inhibitor sirolimus on the proliferation and function of pancreatic islets and ductal cells

verfasst von: C. T. Bussiere, J. R. T. Lakey, A. M. J. Shapiro, G. S. Korbutt

Erschienen in: Diabetologia | Ausgabe 10/2006

Einloggen, um Zugang zu erhalten

Abstract

Aims/hypothesis

The Edmonton Protocol for islet transplantation has provided hope for type 1 diabetic patients. However, this protocol requires lifelong immunosuppression, specifically sirolimus, a cellular antiproliferate. The effect of sirolimus on human pancreatic ductal cells (HDCs) is not known. This may be important since HDCs are believed to be islet precursors. Since neonatal porcine islets (NPIs), which contain many ductal precursor cells, could be a potential clinical source of islets, we also tested the effects of sirolimus on this tissue.

Methods

HDCs (n=4), NPIs (n=9) and human islets (n=5) were cultured with and without sirolimus (20 ng/ml) for 6 days.

Results

HDCs and NPIs cultured with sirolimus showed a 50 and 28% decrease, respectively, in cell number relative to control (p<0.05). Control cultures expanded 1.65- and 2.44-fold relative to time 0. Decreases in cell number of sirolimus-treated HDCs were not due to apoptosis as measured by TUNEL staining. No functional effects on human islets or NPIs were observed following static incubation with high glucose. Treatment of syngeneically transplanted and naïve BALC/c mice with sirolimus resulted in altered OGTT profiles with prolonged elevation of hyperglycaemia and weight gain. There was no difference in graft and organ insulin content between treatment groups.

Conclusions/interpretation

Our results indicate that sirolimus decreases ductal cell numbers in culture and alters glucose-stimulated insulin secretion in vivo. The administration of sirolimus to islet transplant recipients is likely to impair graft function as a result of decreasing ductal neogenesis and induction of insulin resistance.

Ryan EA, Paty BW, Senior PA et al (2005) Five-year follow-up after clinical islet transplantation. Diabetes 54:2060–2069PubMedCrossRef

Shapiro AM, Lakey JR, Ryan EA et al (2000) Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 343:230–238PubMedCrossRef

Seufferlein T, Rozengurt E (1996) Rapamycin inhibits constitutive p70s6k phosphorylation, cell proliferation, and colony formation in small cell lung cancer cells. Cancer Res 56:3895–3897PubMed

Fuhrer DK, Kobayashi M, Jiang H (2001) Insulin release and suppression by tacrolimus, rapamycin and cyclosporin A are through regulation of the ATP-sensitive potassium channel. Diabetes Obes Metab 3:393–402PubMedCrossRef

Paty BW, Harmon JS, Marsh CL, Robertson RP (2002) Inhibitory effects of immunosuppressive drugs on insulin secretion from HIT-T15 cells and Wistar rat islets. Transplantation 73:353–357PubMedCrossRef

Bell E, Cao X, Moibi JA et al (2003) Rapamycin has a deleterious effect on MIN-6 cells and rat and human islets. Diabetes 52:2731–2739PubMedCrossRef

Polastri L, Galbiati F, Bertuzzi F et al (2002) Secretory defects induced by immunosuppressive agents on human pancreatic beta-cells. Acta Diabetol 39:229–233PubMedCrossRef

Hui H, Khoury N, Zhao X et al (2005) Adenovirus-mediated XIAP gene transfer reverses the negative effects of immunosuppressive drugs on insulin secretion and cell viability of isolated human islets. Diabetes 54:424–433PubMedCrossRef

Finegood DT, Scaglia L, Bonner-Weir S (1995) Dynamics of beta-cell mass in the growing rat pancreas. Estimation with a simple mathematical model. Diabetes 44:249–256PubMedCrossRef

10.

Dor Y, Brown J, Martinez OI, Melton DA (2004) Adult pancreatic beta-cells are formed by self-duplication rather than stem-cell differentiation. Nature 429:41–46PubMedCrossRef

11.

Gu G, Brown JR, Melton DA (2003) Direct lineage tracing reveals the ontogeny of pancreatic cell fates during mouse embryogenesis. Mech Dev 120:35–43PubMedCrossRef

12.

Lammert E, Cleaver O, Melton D (2003) Role of endothelial cells in early pancreas and liver development. Mech Dev 120:59–64PubMedCrossRef

13.

Sander M, German MS (1997) The beta cell transcription factors and development of the pancreas. J Mol Med 75:327–340PubMedCrossRef

14.

Bonner-Weir S, Sharma A (2002) Pancreatic stem cells. J Pathol 197:519–526PubMedCrossRef

15.

Peck AB, Cornelius JG, Schatz D, Ramiya VK (2002) Generation of islets of Langerhans from adult pancreatic stem cells. J Hepatobiliary Pancreat Surg 9:704–709PubMedCrossRef

16.

Ianus A, Holz GG, Theise ND, Hussain MA (2003) In vivo derivation of glucose-competent pancreatic endocrine cells from bone marrow without evidence of cell fusion. J Clin Invest 111:843–850PubMedCrossRef

17.

Kodama S, Kuhtreiber W, Fujimura S, Dale EA, Faustman DL (2003) Islet regeneration during the reversal of autoimmune diabetes in NOD mice. Science 302:1223–1227PubMedCrossRef

18.

Zorina TD, Subbotin VM, Bertera S et al (2003) Recovery of the endogenous beta cell function in the NOD model of autoimmune diabetes. Stem Cells 21:377–388PubMedCrossRef

19.

Street CN, Lakey JR, Shapiro AM et al (2004) Islet graft assessment in the Edmonton protocol: implications for predicting long-term clinical outcome. Diabetes 53:3107–3114PubMedCrossRef

20.

Abraham RT, Wiederrecht GJ (1996) Immunopharmacology of rapamycin. Annu Rev Immunol 14:483–510PubMedCrossRef

21.

Bruns CJ, Koehl GE, Guba M et al (2004) Rapamycin-induced endothelial cell death and tumor vessel thrombosis potentiate cytotoxic therapy against pancreatic cancer. Clin Cancer Res 10:2109–2119PubMedCrossRef

22.

Lieberthal W, Fuhro R, Andry CC et al (2001) Rapamycin impairs recovery from acute renal failure: role of cell-cycle arrest and apoptosis of tubular cells. Am J Physiol Renal Physiol 281:F693–F706PubMed

23.

Seufferlein T, Rozengurt E (1996) Rapamycin inhibits constitutive p70s6k phosphorylation, cell proliferation, and colony formation in small cell lung cancer cells. Cancer Res 56:3895–3897PubMed

24.

Zhu J, Wu J, Frizell E et al (1999) Rapamycin inhibits hepatic stellate cell proliferation in vitro and limits fibrogenesis in an in vivo model of liver fibrosis. Gastroenterology 117:1198–1204PubMedCrossRef

25.

Zohlnhofer D, Nuhrenberg TG, Neumann FJ et al (2004) Rapamycin effects transcriptional programs in smooth muscle cells controlling proliferative and inflammatory properties. Mol Pharmacol 65:880–889PubMedCrossRef

26.

Korbutt GS, Elliott JF, Ao Z, Smith DK, Warnock GL, Rajotte RV (1996) Large scale isolation, growth, and function of porcine neonatal islet cells. J Clin Invest 97:2119–2129PubMed

27.

Kin T, Korbutt GS, Kobayashi T, Dufour JM, Rajotte RV (2005) Reversal of diabetes in pancreatectomized pigs after transplantation of neonatal porcine islets. Diabetes 54:1032–1039PubMedCrossRef

28.

Cardona K, Korbutt GS, Milas Z et al (2006) Long-term survival of neonatal porcine islets in nonhuman primates by targeting costimulation pathways. Nat Med 12:304–306PubMedCrossRef

29.

Rose NL, Palcic MM, Shapiro AM, Lakey JR (2004) Endogenous pancreatic enzyme activity levels show no significant effect on human islet isolation yield. Cell Transplant 13:153–160PubMed

30.

Lakey JR, Warnock GL, Shapiro AM et al (1999) Intraductal collagenase delivery into the human pancreas using syringe loading or controlled perfusion. Cell Transplant 8:285–292PubMed

31.

Street CN, Lakey JR, Rajotte R et al (2004) Enriched human pancreatic ductal cultures obtained from selective death of acinar cells express pancreatic and duodenal homeobox gene-1 age dependently. The Review of Diabetic Studies 1:66–79PubMedCrossRef

32.

Ohzato H, Gotoh M, Monden M, Dono K, Kanai T, Mori T (1991) Improvement in islet yield from a cold-preserved pancreas by pancreatic ductal collagenase distention at the time of harvesting. Transplantation 51:566–570PubMedCrossRef

33.

Bonner-Weir S, Taneja M, Weir GC et al (2000) In vitro cultivation of human islets from expanded ductal tissue. Proc Natl Acad Sci USA 97:7999–8004PubMedCrossRef

34.

Korbutt GS, Pipeleers DG (1992) Cold storage of rat pancreas before purification of islet beta-cells. Diabetes 41:299–307PubMedCrossRef

35.

Sehgal SN (2003) Sirolimus: its discovery, biological properties, and mechanism of action. Transplant Proc 35:7S–14SPubMedCrossRef

36.

Bell A, Grunder L, Sorisky A (2000) Rapamycin inhibits human adipocyte differentiation in primary culture. Obes Res 8:249–254PubMedCrossRef

37.

Shapiro AM, Gallant HL, Hao EG et al (2005) The portal immunosuppressive storm: relevance to islet transplantation? Ther Drug Monit 27:35–37PubMedCrossRef

38.

Markmann JF, Deng S, Huang X et al (2003) Insulin independence following isolated islet transplantation and single islet infusions. Ann Surg 237:741–749PubMedCrossRef

39.

Danielsson A, Ost A, Nystrom FH, Stralfors P (2005) Attenuation of insulin-stimulated insulin receptor substrate-1 serine 307 phosphorylation in insulin resistance of type 2 diabetes. J Biol Chem 280:34389–34392PubMedCrossRef

40.

Azpiazu I, Saltiel AR, DePaoli-Roach AA, Lawrence JC (1996) Regulation of both glycogen synthase and PHAS-I by insulin in rat skeletal muscle involves mitogen-activated protein kinase-independent and rapamycin-sensitive pathways. J Biol Chem 271:5033–5039PubMedCrossRef

41.

Hurel SJ, Rochford JJ, Borthwick AC et al (1996) Insulin action in cultured human myoblasts: contribution of different signalling pathways to regulation of glycogen synthesis. Biochem J 320:871–877PubMed

42.

Adams AB, Shirasugi N, Durham MM et al (2002) Calcineurin inhibitor-free CD28 blockade-based protocol protects allogeneic islets in nonhuman primates. Diabetes 51:265–270PubMedCrossRef

43.

Tedesco-Silva H, Mourad G, Kahan BD et al (2005) FTY720, a novel immunomodulator: efficacy and safety results from the first phase 2A study in de novo renal transplantation. Transplantation 79:1553–1560PubMedCrossRef

Titel: The impact of the mTOR inhibitor sirolimus on the proliferation and function of pancreatic islets and ductal cells
verfasst von: C. T. Bussiere
J. R. T. Lakey
A. M. J. Shapiro
G. S. Korbutt
Publikationsdatum: 01.10.2006
Verlag: Springer-Verlag
Erschienen in: Diabetologia / Ausgabe 10/2006
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI: https://doi.org/10.1007/s00125-006-0374-5

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Aims/hypothesis

Methods

Results

Conclusions/interpretation

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 10/2006

Altered cerebral regulation in type 2 diabetic patients with cardiac autonomic neuropathy

Type 2 diabetes and cardiovascular risk in the UK south Asian community

Improvements in glucose tolerance and insulin sensitivity after lifestyle intervention are related to changes in serum fatty acid profile and desaturase activities: the SLIM study

Inhibition of p38 mitogen-activated protein kinase attenuates left ventricular dysfunction by mediating pro-inflammatory cardiac cytokine levels in a mouse model of diabetes mellitus

The health-related utility and health-related quality of life of hospital-treated subjects with type 1 or type 2 diabetes with particular reference to differing severity of peripheral neuropathy